Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease

被引:103
作者
Mullin, Stephen [1 ]
Schapira, Anthony H. V. [1 ]
机构
[1] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England
基金
英国惠康基金;
关键词
Parkinson disease; alpha-Synuclein; Lewy bodies; Mitochondrial dysfunction; AUTOSOMAL-DOMINANT PARKINSONISM; CHAPERONE-MEDIATED AUTOPHAGY; ALPHA-SYNUCLEIN AGGREGATION; G2019S LRRK2 MUTATION; LEWY BODY PATHOLOGY; GAUCHER-DISEASE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; COMPLEX-I; GENOMEWIDE ASSOCIATION;
D O I
10.1016/j.ncl.2014.09.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The last 2 decades represent a period of unparalleled advancement in the understanding of the pathogenesis of Parkinson disease (PD). The discovery of several forms of familial parkinsonism with mendelian inheritance has elucidated insights into the mechanisms underlying the degeneration of dopaminergic neurons of the substantia nigra that histologically characterize PD. alpha-Synuclein, the principal component of Lewy bodies, remains the presumed pathogen at the heart of the current model; however, concurrently, a diverse range of other mechanisms have been implicated. The creation of a coherent disease model will be crucial to the development of effective disease modifying therapies for sporadic PD.
引用
收藏
页码:1 / +
页数:18
相关论文
共 50 条
  • [41] The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease
    Chen, Zixuan
    Rasheed, Madiha
    Deng, Yulin
    BRAIN PATHOLOGY, 2022, 32 (03)
  • [42] Oxidative Stress Mechanisms Underlying Parkinson's Disease-Associated Neurodegeneration in C. elegans
    Chakraborty, Sudipta
    Bornhorst, Julia
    Nguyen, Thuy T.
    Aschner, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11): : 23103 - 23128
  • [43] Molecular mechanisms of neurodegeneration in Parkinson's disease: Clues from Mendelian syndromes
    Lim, KL
    Lim, TM
    IUBMB LIFE, 2003, 55 (06) : 315 - 322
  • [44] MOLECULAR MECHANISMS OF PATHOGENESIS OF PARKINSON'S DISEASE
    Shadrina, M. I.
    Slominsky, P. A.
    Limborska, S. A.
    INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 281, 2010, 281 : 229 - 266
  • [45] Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease
    Mori, Akio
    Imai, Yuzuru
    Hattori, Nobutaka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [46] Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues
    Menozzi, Elisa
    Toffoli, Marco
    Schapira, Anthony H. V.
    PHARMACOLOGY & THERAPEUTICS, 2023, 246
  • [47] Natural Products Combating Neurodegeneration: Parkinson's Disease
    Solayman, Md.
    Islam, Md. Asiful
    Alam, Fahmida
    Khalil, Md. Ibrahim
    Kamal, Mohammad Amjad
    Gan, Siew Hua
    CURRENT DRUG METABOLISM, 2017, 18 (01) : 50 - 61
  • [48] Microbial BMAA and the Pathway for Parkinson's Disease Neurodegeneration
    Nunes-Costa, Daniela
    Magalhaes, Joao Duarte
    G-Fernandes, Maria
    Cardoso, Sandra Morais
    Empadinhas, Nuno
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [49] Common pathogenic pathways in melanoma and Parkinson disease
    Paisan-Ruiz, Coro
    Houlden, Henry
    NEUROLOGY, 2010, 75 (18) : 1653 - 1655
  • [50] Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson's Disease
    Kolacheva, Anna
    Bannikova, Alyona
    Pavlova, Ekaterina
    Bogdanov, Vsevolod
    Ugrumov, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)